Glucagon-like peptide-1
US$ 26.75
common side effects of glp-1 receptor agonists GI Adverse Glucagon-Like Peptide-1 The expanding role of GLP-1
Description
The messaging is about affordability and access
Theyre nothing like Ozempic.
Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users
Federal law does not require many compounders to report adverse events to FDA
GLP-1RA only reduced the risk of nonfatal stroke
